205
Aclaris Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
232
FY23:
129
FY24:
126
FY25:
96.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
46.2
FY22:
23.0
FY23:
68.5
FY24:
94.4
FY25:
64.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
251
FY22:
255
FY23:
197
FY24:
220
FY25:
160
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
22.9
FY22:
21.9
FY23:
31.0
FY24:
31.6
FY25:
28.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
30.9
FY22:
35.0
FY23:
9.27
FY24:
33.2
FY25:
28.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
197
FY22:
198
FY23:
157
FY24:
156
FY25:
103
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
251
FY22:
255
FY23:
197
FY24:
220
FY25:
160
All amounts in millions USD